Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Mar;18(2):161-6.
doi: 10.1023/a:1023255102170.

Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases

Affiliations

Primary immunodeficiency diseases in Latin America: first report from eight countries participating in the LAGID. Latin American Group for Primary Immunodeficiency Diseases

M Zelazko et al. J Clin Immunol. 1998 Mar.

Abstract

The Latin American Group for Primary Immunodeficiencies, formed in 1993, presently includes 12 countries. One goal was to study the frequency of primary immunodeficiencies in various regions of the American continent and to enhance knowledge about these diseases among primary-care physicians, as well as allergist-immunologists. Important for this purpose was the development of a registry of primary immunodeficiencies using a uniform questionnaire and computerized database. To date, eight countries have collected information on a total of 1428 patients. Predominantly antibody deficiencies were reported in 58% of patients, followed by cellular and antibody immunodeficiencies associated with other abnormalities in 18%, immunodeficiency syndromes associated with granulocyte dysfunction in 8%, phagocytic disorders in 9%, combined cellular and antibody immunodeficiencies in 5%, and complement deficiencies in 2% of patients. The information gathered from this initial analysis of data will serve to expand the patient database to more areas within participating countries and to new countries and to increase collaboration toward better diagnosis and treatment of these diseases.

PubMed Disclaimer

References

    1. J Clin Immunol. 1997 Jul;17(4):340-5 - PubMed
    1. J Clin Immunol. 1988 Nov;8(6):479-85 - PubMed
    1. J Clin Immunol. 1983 Oct;3(4):316-20 - PubMed
    1. Clin Exp Immunol. 1995 Jan;99 Suppl 1:1-24 - PubMed
    1. Allergol Immunopathol (Madr). 1989 Jul-Aug;17(4):213-6 - PubMed

Publication types

MeSH terms

LinkOut - more resources